The Nasdaq Biotechnology Index now includes Guilford biotech firm Quantum-Si. The Biotechnology Index tracks the performance of a select group of biotechnology or pharmaceutical securities.
Nasdaq indexed companies must meet a set of standards including minimum market capitalization, average daily trading volume and seasoning as a public company, among other criteria.